21
TITLE: Overview of pharmacology-induced mechanisms of carcinogenesis  Full Text
AUTHORS: Jan Willem Van der Laan; Peter Kasper; Beatriz Silva Lima; David Jones; Markku Pasanen;
PUBLISHED: 2016, SOURCE: 52nd Congress of the European-Societies-of-Toxicology (EUROTOX) in TOXICOLOGY LETTERS, VOLUME: 258
INDEXED IN: WOS
23
TITLE: Contribution of animal studies to evaluate the similarity of biosimilars to refrence products  Full Text
AUTHORS: Peter J K van Meer; Hans C Ebbers; Marlous Kooijman; Christine C Gispen de Wied; Beatriz Silva Lima; Ellen H M Moors; Huub Schellekens;
PUBLISHED: 2015, SOURCE: DRUG DISCOVERY TODAY, VOLUME: 20, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
25
TITLE: Regulatory Aspects
AUTHORS: Lima, BS;
PUBLISHED: 2015, SOURCE: Predictive Toxicology: From Vision to Reality
INDEXED IN: Scopus CrossRef
IN MY: ORCID
26
TITLE: Considerations Regarding the Future Use of Nonhuman Primates to Support the Clinical Development of Biopharmaceuticals
AUTHORS: Cavagnaro, JA; Lima, BS;
PUBLISHED: 2015, SOURCE: The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment
INDEXED IN: Scopus CrossRef
IN MY: ORCID
27
TITLE: Oral supplementation with fish oil reduces dryness and pruritus in the acetone-induced dry skin rat model  Full Text
AUTHORS: Raquel C S Barcelos; Cris Tina de Mello Sampay; Caren T D Antoniazzi; Hecson J Segat; Henrique Silva; Juliana C Veit; Jaqueline Piccolo; Tatiana Emanuelli; Marilise E Buerger; Beatriz Silva Lima; Luis M Rodrigues;
PUBLISHED: 2015, SOURCE: JOURNAL OF DERMATOLOGICAL SCIENCE, VOLUME: 79, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
28
TITLE: Nonclinical Strategies for Investigating Potential Tumor Signals Detected in Clinical Trials
AUTHORS: Lorrene A Buckley; Beatriz Silva Lima; Mark A Tirmenstein;
PUBLISHED: 2015, SOURCE: Genotoxicity and Carcinogenicity Testing of Pharmaceuticals
INDEXED IN: Scopus CrossRef: 1
IN MY: ORCID
29
TITLE: Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials
AUTHORS: Sewell, F; Chapman, K; Baldrick, P; Brewster, D; Broadmeadow, A; Brown, P; Burns Naas, LA; Clarke, J; Constan, A; Couch, J; Czupalla, O; Danks, A; DeGeorge, J; de Haanm, L; Hettinger, K; Hill, M; Festag, M; Jacobs, A; Jacobson Kram, D; Kopytek, S; Lorenz, H; Moesgaard, SG; Moore, E; Pasanen, M; Perry, R; Ragan, I; Robinson, S; Schmitt, PM; Short, B; Lima, BS; Smith, D; Sparrow, S; van Bekkum, Y; Jones, D; ...More
PUBLISHED: 2014, SOURCE: REGULATORY TOXICOLOGY AND PHARMACOLOGY, VOLUME: 70, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
30
TITLE: White Paper on How to Go Forward with Cell-Based Advanced Therapies in Europe
AUTHORS: Reinhold G Erben; Beatriz Silva Lima; Ilona Reischl; Gustav Steinhoff; Gudrun Tiedemann; Wilfried Dalemans; Alexander Vos; Rob T A Janssen; Katarina Le Blanc; Gerjo J V M van Osch; Frank P Luyten;
PUBLISHED: 2014, SOURCE: TISSUE ENGINEERING PART A, VOLUME: 20, ISSUE: 19-20
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
Page 3 of 5. Total results: 49.